JAVELIN Head & Neck 100

The JAVELIN Head & Neck 100 trial is the first of its kind to open in Ireland. It increases treatment opportunities for some Irish patients. It is a Phase III double-blind randomised controlled trial (RCT) studying the effect of avelumab, versus placebo, in combination with standard of care CRT in the frontline treatment of patients […]

Publications update

Here’s a list of the 14 publications in academic peer reviewed journals since the last DSSG Digest (Spring) in which Cancer Trials Ireland investigators participated. If you would like your publications included in our next listing please contact orla.casey@cancertrials.ie Compiled by Dr Orla Casey, Translational Project Manager, Cancer Trials Ireland Publications update

DSSG Autumn 2018

At our Autumn DSSG /Scientific meeting, which coincided with the 2018 Gathering Around Cancer hosted at Croke Park, the GU Cancer Research meeting welcomed our new patient consultant Eddie MacEoin (left). Pictured with Eddie is Eibhlin Mulroe, CEO of Cancer Trials Ireland, and Jonathon Westrup, Chair of the Board of Cancer Trials Ireland. Also pictured […]


Pictured at Cancer Trials Ireland’s AGM at Croke Park which coincided with the 2019 Gathering Around Cancer and the organisation’s Autumn Scientific meeting were (l to r) Board members Dr Linda Coate, Vice Clinical Lead, Cancer Trials Ireland; Dr Rob O’Connor, Head of Research, Irish Cancer Society; Dr Jonathan Westrup, Chair of the Board; Dr […]

1 in 4 women on study avoided chemotherapy 

Congratulations to Dr Patrick Morris, Consultant Medical Oncologist at Beaumont Hospital Dublin, and his team for presenting exciting results of the Cancer Trials Ireland sponsored  Gene Recurrence Score Study at ESMO2018. Pictured at the poster presentation at ESMO2018 Dr Anees Hassan, Dr Verena Murphy and Dr Kathleen Scott. 1 in 4 women on breast cancer study avoided […]

ESMO 2018

We’re delighted to be at ESMO2018.  In all, our teams will present seven abstracts and posters.  Pictured at the poster announcing some results of the Cancer Trial Ireland sponsored trial PantHER is Dr Sinead Toomey,  Translational oncology lecturer and research scientist based in RCSI, Dublin. Monitoring the effect of PI3K inhibition on HER2 therapy resistant breast […]